๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
HLS Therapeutics Inc. (TSX:HLS)
Canada flag Canada ยท Delayed Price ยท Currency is CAD
3.670
-0.090 (-2.39%)
Nov 19, 2026, 4:00 PM EST

HLS Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
56.8955.556.6263.0761.4760.01
Revenue Growth
1.86%-1.98%-10.23%2.61%2.43%6.95%
Gross Profit
39.7639.7141.9649.8850.7650.36
Operating Income
-3.92-4.11-7.69-10.35-13.5-6.28
Net Income
-6.88-12.43-19.66-27.53-23.6-13.12
Earnings Per Share
-0.22-0.39-0.62-0.85-0.73-0.41
EPS Growth
------

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Canada
42.4742.6539.2937.0234.69
United States
12.5613.1918.4719.5620.17
Rest of World
0.480.795.314.885.15
Total
55.556.6263.0761.4760.01

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.4111.7217.4621.9520.7221.18
Total Debt
45.9349.8266.4587.6297.3597.57
Net Cash (Debt)
-34.51-38.1-48.99-65.67-76.62-76.39
Net Cash Growth
------
Net Cash Per Share
-1.12-1.21-1.54-2.04-2.36-2.37

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
17.5517.13815.7916.9416.43
Capital Expenditures
-0.03-0.21-0.02-0.04-0.05-0.05
Free Cash Flow
17.5116.937.9915.7516.916.38
Free Cash Flow Growth
28.37%111.88%-49.28%-6.80%3.14%76.00%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.88%71.55%74.11%79.07%82.58%83.92%
Operating Margin
-6.90%-7.40%-13.58%-16.41%-21.96%-10.47%
Pretax Margin
-13.22%-23.20%-27.52%-44.08%-38.59%-19.68%
Profit Margin
-12.09%-22.40%-34.71%-43.65%-38.39%-21.86%
FCF Margin
30.79%30.50%14.11%24.97%27.49%27.30%

Dividends

Fiscal Year
FY 2023FY 2022FY 2021
Period EndingDec '23 Dec '22 Dec '21
Dividend Per Share
0.0760.1480.158
Dividend Per Share Growth
-48.76%-6.50%0.69%
Dividend Yield
2.52%2.03%1.33%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-50.9250.9250.9250.92185.98
P/FCF Ratio
4.606.5010.876.0913.9223.48
PS Ratio
1.421.981.531.523.836.41